Advertisement

Traitement de la défaillance cardiaque

  • S. Marqué
  • A. Cariou
Part of the Le point sur⋯ book series (POINT)

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. 1.
    Parker MM, Natanson C, Ognibene FP et al. (1989) Responses of left ventricule function in survivors and non survivors of septic shock. J Crit Care 4: 19–25CrossRefGoogle Scholar
  2. 2.
    Grocott-Mason RM, Shah AM (1998) Cardiac dysfunction in sepsis: new theories and clinical implications. Intensive Care Med 24(4): 286–95CrossRefPubMedGoogle Scholar
  3. 3.
    Parker MM, Shelhamer JH, Bacharach SL et al. (1984) Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med 100(4): 483–90PubMedGoogle Scholar
  4. 4.
    Genaud P, Vinsonneau C, Cariou A (2001) Dysfonction myocardique du sepsis: physiopathologie et perspectives thérapeutiques. Réanimation 10(2)Google Scholar
  5. 5.
    SRLF (1996) Utilisation des catécholamines au cours du choc septique. In XVe Conférence de consensus de la SRLF, LilleGoogle Scholar
  6. 6.
    Henning RJ, Weil MH (1978) Effect of afterload reduction on plasma volume during acute heart failure. Am J Cardiol 42(5): 823–7CrossRefPubMedGoogle Scholar
  7. 7.
    Schneider AJ, Teule GJ, Groeneveld AB et al. (1988) Biventricular performance during volume loading in patients with early septic shock, with emphasis on the right ventricle: a combined hemodynamic and radionuclide study. Am Heart J 116(1): 103–2CrossRefPubMedGoogle Scholar
  8. 8.
    TFACCCM (1999) Practice parameters for hemodynamic support of sepsis in adult patients in sepsis. Crit Care Med 27(3): 639–60Google Scholar
  9. 9.
    Packman MI, Rackow EC (1983) Optimum left heart filling pressure during fluid resuscitation of patients with hypovolemic and septic shock. Crit Care Med 11(3): 165–9PubMedGoogle Scholar
  10. 10.
    Wagner JG, Leatherman JW (1998) Right ventricular end-diastolic volume as a predictor of the hemodynamic response to a fluid challenge. Chest 113(4): 1048–54PubMedGoogle Scholar
  11. 11.
    Raper R, Sibbald WJ (1986) Misled by the wedge? The Swan-Ganz catheter and left ventricular preload. Chest 89(3): 427–34PubMedGoogle Scholar
  12. 12.
    Michard F, Teboul J (2002) Predicting fluid responsiveness in ICU patients: a critical analysis of the evidence. Chest 121(6): 2000–8CrossRefPubMedGoogle Scholar
  13. 13.
    Schreuder WO, Schneider AJ, Groeneveld AB, Thijs LG (1989) Effect of dopamine vs norepinephrine on hemodynamics in septic shock. Emphasis on right ventricular performance. Chest 95(6): 1282–8PubMedGoogle Scholar
  14. 14.
    Shoemaker WC, Czer LS (1979) Evaluation of the biologic importance of various hemodynamic and oxygen transport variables: which variables should be monitored in postoperative shock? Crit Care Med 7(9): 424–31PubMedGoogle Scholar
  15. 15.
    Vincent JL, Roman A, Kahn RJ (1990) Dobutamine administration in septic shock: addition to a standard protocol. Crit Care Med 18(7): 689–93PubMedGoogle Scholar
  16. 16.
    Gattinoni L, Brazzi L, Pelosi P et al. (1995) A trial of goal-oriented hemodynamic therapy in critically ill patients. S-vO2 Collaborative Group. N Engl J Med 333(16): 1025–32CrossRefPubMedGoogle Scholar
  17. 17.
    Hayes MA, Timmins AC, Yau EH et al. (1994) Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med, 330(24): 1717–22CrossRefPubMedGoogle Scholar
  18. 18.
    Vallet B, Chopin C (2000) The supranormal oxygen delivery trials controversy. Dobutamine in Sepsis Study Group. Crit Care Med, 28(4): 1257–8PubMedGoogle Scholar
  19. 19.
    Levy B, Bollaert PE, Lucchelli JP et al. (1997) Dobutamine improves the adequacy of gastric mucosal perfusion in epinephrine-treated septic shock. Crit Care Med, 1997. 25(10): 1649–54PubMedGoogle Scholar
  20. 20.
    Desjars P, Pinaud M, Bugnon D, Tasseau F (1988) Norepinephrine therapy has no deleterious renal effects in human septic shock. Crit Care Med 17(5): 426–9Google Scholar
  21. 21.
    Meadows D, Edwards JD, Wilkins RG, Nightingale P (1988) Reversal of intractable septic shock with norepinephrine therapy. Crit Care Med 16(7): 663–6PubMedGoogle Scholar
  22. 22.
    Hesselvik JF, Brodin B (1989) Low dose norepinephrine in patients with septic shock and oliguria: effects on afterload, urine flow, and oxygen transport. Crit Care Med 17(2): 179–80PubMedGoogle Scholar
  23. 23.
    LeDoux D, Astiz ME, Carpati CM, Rackow EC (2000) Effects of perfusion pressure on tissue perfusion in septic shock. Crit Care Med 28(8): 2729–32PubMedGoogle Scholar
  24. 24.
    Lipman J, Roux A, Kraus P (1991) Vasoconstrictor effects of adrenaline in human septic shock. Anaesth Intensive Care 19(1): 61–5PubMedGoogle Scholar
  25. 25.
    Le Tulzo Y, Seguin P, Gacouin A et al. (1997) Effects of epinephrine on right ventricular function in patients with severe septic shock and right ventricular failure: a preliminary descriptive study. Intensive Care Med 23(6): 664–70CrossRefPubMedGoogle Scholar
  26. 26.
    Leier CV, Binkley PF, Carpenter J et al. (1988) Cardiovascular pharmacology of dopexamine in low output congestive heart failure. Am J Cardiol 62(1): 94–9CrossRefPubMedGoogle Scholar
  27. 27.
    Leather HA, Segers P, Berends N et al. (2002) Effects of vasopressin on right ventricular function in an experimental model of acute pulmonary hypertension. Crit Care Med 30(11): 2548–52PubMedGoogle Scholar
  28. 28.
    Dunser MW, Mayr AJ, Ulmer H et al. (2003) Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study. Circulation 107(18): 2313–9CrossRefPubMedGoogle Scholar
  29. 29.
    Westphal M, Stubbe H, Sielenkamper AW et al. (2003) Effects of titrated arginine vasopressin on hemodynamic variables and oxygen transport in healthy and endotoxemic sheep. Crit Care Med, 31(5): 1502–8PubMedGoogle Scholar
  30. 30.
    Krafte-Jacobs B, Brilli R, Szabo C et al. (1997) Circulating methemoglobin and nitrite/nitrate concentrations as indicators of nitric oxide overproduction in critically ill children with septic shock. Crit Care Med 25(9): 1588–93PubMedGoogle Scholar
  31. 31.
    Mohan P, Brutsaert DL, Paulus WJ, Sys SU (1996) Myocardial contractile response to nitric oxide and cGMP. Circulation 93(6): 1223–9PubMedGoogle Scholar
  32. 32.
    Freeman BD, Cobb JP (1998) Nitric oxide synthase as a therapeutic target in sepsis—more questions than answers? Crit Care Med 26(9): 1469–70PubMedGoogle Scholar
  33. 33.
    Avontuur JA, Tutein Nolthenius RP et al. (1998) Effect of L-NAME, an inhibitor of nitric oxide synthesis, on cardiopulmonary function in human septic shock. Chest 113(6): 1640–6PubMedGoogle Scholar
  34. 34.
    Preiser JC, Lejeune P, Roman A et al. (1995) Methylene blue administration in septic shock: a clinical trial. Crit Care Med 23(2): 259–64PubMedGoogle Scholar
  35. 35.
    Kirov MY, Evgenov OV, Evgenov NV et al. (2001) Infusion of methylene blue in human septic shock: a pilot, randomized, controlled study. Crit Care Med 29(10): 1860–7PubMedGoogle Scholar
  36. 36.
    Buwalda M, Ince C (2002) Opening the microcirculation: can vasodilators be useful in sepsis? Intensive Care Med 28(9): 1208–17CrossRefPubMedGoogle Scholar
  37. 37.
    Hache M, Denault A, Belisle S et al. (2003) Inhaled epoprostenol (prostacyclin) and pulmonary hypertension before cardiac surgery. J Thorac Cardiovasc Surg 125(3): 642–9CrossRefPubMedGoogle Scholar
  38. 38.
    Gomez A, Wang R, Unruh H et al. (1990) Hemofiltration reverses left ventricular dysfunction during sepsis in dogs. Anesthesiology 73(4): 671–85PubMedGoogle Scholar
  39. 39.
    Grootendorst AF, Van Bommel EF, Van der Hoven B et al. (1992) High volume hemofiltration improves right ventricular function in endotoxin-induced shock in the pig. Intensive Care Med 18(4): 235–40CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag France 2005

Authors and Affiliations

  • S. Marqué
  • A. Cariou

There are no affiliations available

Personalised recommendations